Severity
Moderate
FDA Drug recall · Reported June 20, 2012
Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this product because they may contain broken tablets.
Physicians Total Care, Inc. recalled Arthrotec 75 (diclofenac sodium and misoprostol) tablets, 75 mg/200 mcg, a) 30-count tabl… - a moderate-severity action.
Arthrotec 75 (diclofenac sodium and misoprostol) tablets, 75 mg/200 mcg, a) 30-count tabl… was recalled by Physicians Total Care, Inc. in June 20, 2012. Reason: Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this prod…. Check the official notice for the remedy. Verify recall #D-1379-2012 with the FDA Drug before acting.
The recall
Physicians Total Care, Inc. issued this moderate-severity FDA Drug recall-Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this prod….
Sourced from official FDA Drug enforcement records. Verify recall #D-1379-2012 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1379-2012) was formally reported on June 20, 2012, with the manufacturer initiating the action on September 19, 2011. It is classified under Moderate severity (Class II), with a current status of Terminated. Physicians Total Care, Inc. is listed as the recalling firm, operating out of Tulsa, OK. Federal records list the affected scope as a) 4 bottles; b) 2 bottles.
The documented reason for this recall is: Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this product because they may contain broken tablets. Distribution data in the federal record shows the product reached: NC and KY. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
a) 4 bottles; b) 2 bottles
Related Recalls
6
5 from same agency
Arthrotec 75 (diclofenac sodium and misoprostol) tablets, 75 mg/200 mcg, a) 30-count tablets per bottle (NDC 54868-4165-1); b) 60-count tablets per bottle (NDC 54868-4165-0); Rx only, Mfg. By: G.D. searle LLC Div Pfizer, New York, NY 10017; Repacked & distributed by: Physicians total Care, Inc., Tulsa, OK 74146.
Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this product because they may contain broken tablets.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-1379-2012 |
| Date reported | June 20, 2012 |
| Date initiated | September 19, 2011 |
| Recalling firm | Physicians Total Care, Inc. |
| Firm location | Tulsa, OK |
| Affected scope | a) 4 bottles; b) 2 bottles |
| Distribution | NC and KY |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported June 20, 2012. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.